Earli is a BioAI therapeutics firm in Redwood City, California that programs cancer to turn against itself. Cancer cells become hyperlocal factories for potent immune therapies that are otherwise too toxic to be used systemically . Earli AI-designs synthetic genetic switches that are intravenously injected but ONLY activate in cancer cells, using non-integrating DNA in a stealth LNP. Once activated, they force the cancer cells to produce encoded proteins – T cell engagers, cytokines, agonists – that activate the immune system to kill the cancer. The hyperlocal activation avoids on-target/off-tumor effects and drives up the therapeutic index. Instead of focusing on where the drug goes , Earli changes where the drug is produced . Earli is currently seeking a highly motivated Research Associate/Senior Research Associate to join the Molecular Analysis team as a 4-month contract position . The successful candidate will play a key role in the molecular analysis of the Earli platform technology by supporting efforts to process tissue samples, extract high-quality nucleic acids, and run qPCR and RT-qPCR assays.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Entry Level
Number of Employees
1-10 employees